CLIC2

protein-coding

chloride intracellular channel 2, the group of Chloride intracellular channels

Gene summary

This gene encodes a chloride intracellular channel protein. Chloride channels are a diverse group of proteins that regulate fundamental cellular processes including stabilization of cell membrane potential, transepithelial transport, maintenance of intracellular pH, and regulation of cell volume. This protein plays a role in inhibiting the function of ryanodine receptor 2. A mutation in this gene is the cause of an X-linked form of cognitive disability. [provided by RefSeq, Jul 2017]

MANE transcript

NM_001289.6

Inheritance

XL

ClinVar variants

U:65B:13

Top phenotype

Intellectual developmental disorder, X-linked, syndromic 32

gnomAD constraint

pLI —, LoF o/e 0.42

Max pathogenic AF

—

Genomic locus

chrX:155,276,211-155,334,657

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~58.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

intellectual developmental disorder, X-linked, syndromic 32LIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0010473

Submitter: Labcorp Genetics (formerly Invitae)

intellectual developmental disorder, X-linked, syndromic 32LIMITED

Inheritance Pattern: XL

Disease ID:MONDO:0010473

Submitter: G2P

intellectual developmental disorder, X-linked, syndromic 32MODERATE

Inheritance Pattern: XL

Disease ID:MONDO:0010473

Submitter: Genomics England PanelApp

X-linked complex neurodevelopmental disorderNO_KNOWN

Inheritance Pattern: XL

Disease ID:MONDO:0100148

Submitter: ClinGen

CLIC2 was first reported in relation to X-linked complex neurodevelopmental disorder in 2012 by Takano et al., PMID: 22814392. The three individuals (from two unrelated families) reported to date in the literature with variants in this gene had phenotypes including intellectual disability, delayed psychomotor development, seizures, and adult onset cardiac issues such as congestive heart failure, valvular insufficiency, atrial fibrillation, and cardiomegaly. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism, inheritance pattern, or phenotypic variability. Therefore, for the purposes of this curation, all of the reported disease entities, including syndromic X-linked mental retardation-32 (OMIM # 300886) and X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome (ORPHA:324410, MONDO:0010473) have been lumped into one disease entity: X-linked complex neurodevelopmental disorder. Although two unique variants (both missense) have been reported in humans, the first published variant (Takano et al., PMID: 22814392) has been ruled out from disease-causality based on the presence of this variant in adult males in the (non-neuro) gnomAD population database (v.2.1.1). Given the dearth of experimental evidence linking CLIC2 with disease, and the scarcity of plausible reports of disease-causing variants in humans, the ClinGen Intellectual Disability and Autism Working Group recommended awarding 0 points for the second published variant, a missense change with no supportive functional data (Vissers et al., PMID: 28333917). In summary, there is disputed evidence supporting the relationship between CLIC2 and X-linked complex neurodevelopmental disorder. More evidence is needed to either support or refute the role CLIC2 plays in this disease. This classification was approved by the ClinGen Intellectual Disability and Autism Working Group on 2/16/2021 (SOP Version 8).

intellectual developmental disorder, X-linked, syndromic 32SUPPORTIVE

Inheritance Pattern: XL

Disease ID:MONDO:0010473

Submitter: Orphanet

intellectual developmental disorder, X-linked, syndromic 32NO_KNOWN

Inheritance Pattern: XL

Disease ID:MONDO:0010473

Submitter: Ambry Genetics

Clinical Genomic Database (CGD)

Intellectual developmental disorder, X-linked, syndromic 32XL

Manifestation: Cardiovascular; Musculoskeletal; Neurologic

Intervention: Cardiovascular

Rationale: Among other manifestations, individuals have been described as including cardiac findings such as atrial fibrillation, congestive heart failure, valvular insufficiency, and awareness may allow surveillance and early medical management

Refs: 22814392Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CLIC2 variants in ClinVar

4 Conditions Cataloged
not specifiedTotal: 36
not providedTotal: 14
X-linked intellectual disability-cardiomegaly-congestive heart failure syndromeTotal: 6
CLIC2-related disorderTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001289.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
7
clinvar
13
missense
44
clinvar
6
clinvar
50
nonsense
3
clinvar
3
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
12
clinvar
12
Total006513078
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 7 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001289.6RefSeqNP_001280.36MANE Select
ENST00000369449.7EnsemblENSP00000358460.26MANE Select
ENST00000321926.4EnsemblENSP00000318558.44Standard
ENST00000948941.1EnsemblENSP00000619000.17Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Pantoprazole Action Pathway
  • Rabeprazole Action Pathway
  • Esomeprazole Action Pathway
  • Omeprazole Action Pathway
  • Lansoprazole Action Pathway

Biological Process

  • signal transduction
  • regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
  • regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
  • positive regulation of binding
  • negative regulation of ryanodine-sensitive calcium-release channel activity

Molecular Function

  • glutathione transferase activity
  • glutathione peroxidase activity
  • voltage-gated ion channel activity
  • chloride channel activity
  • protein binding

Cellular Component

  • nucleus
  • cytoplasm
  • chloride channel complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000369449
Coding exons
6
Length
58467
Individuals with no LoFs
125735
Homozygous LoFs
1
Heterozygous LoFs
3
Defined
125739
p
0.0000159
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.275892.40.6280.000006991632
Missense (PolyPhen)1441.3980.33818721
Synonymous0.1183333.90.9740.00000249455
Loss of Function1.4337.130.4214.46e-7152

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000760.000062rare
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.0000720.000054rare
Finnish00.0absent
European (Non-Finnish)0.0000250.000018rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Can insert into membranes and form chloride ion channels. Channel activity depends on the pH. Membrane insertion seems to be redox-regulated and may occur only under oxydizing conditions. Modulates the activity of RYR2 and inhibits calcium influx. {ECO:0000269|PubMed:15147738, ECO:0000269|PubMed:15916532, ECO:0000269|PubMed:17945253}.;
Disease
DISEASE: Mental retardation, X-linked, syndromic, 32 (MRXS32) [MIM:300886]: A mental retardation syndrome characterized by profound intellectual deficit, delayed psychomotor development beginning in infancy and little or no speech development. Additional features include seizures, large joint contractures, and abnormal positioning of the thumbs. Mental retardation is defined by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:22814392}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.140

Intolerance Scores

LoFtool
0.140
RVIS EVS
0.19
RVIS percentile EVS
66.57

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.903

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.